Key Takeaways
- Record quarter, margin spike is one-off: Revenue, EBITDA and PAT hit all-time highs, but the 18% EBITDA margin is an exception driven by a new subsidy release, not a new run-rate; sustainable margin stays at 12–14%.
- Dhule plant commissioned, sales imminent: The 3,30,000 MTPA DAP/NPK and captive phosphoric acid plants are built and commissioned; commercial sales expected to begin within 10 days, with utilization guided at 40–50%.
- H1 NPK/DAP sales slipped, recovery promised: A marginal H1 volume decline from raw material and transit disruptions; management confident of making it up in coming quarters through manufacturing plus imports.
- Balance sheet stretched temporarily: Trade receivables swelled to ₹632 crores on lopsided Q2 sales from a delayed monsoon; described as a one-time aberration to be corrected over the next six months.
- What to watch next quarter: Whether Dhule commercial sales actually start and ramp toward the 40–50% utilization target, whether the receivables book begins to normalize, and whether the promised NPK/DAP volume catch-up materializes.
Dhule Commissioning & Capacity Ramp
- Plant status: Both the 3,30,000 MTPA DAP/NPK fertilizer unit and the 99,000 MTPA captive phosphoric acid plant at Dhule, Maharashtra have been successfully commissioned. Commercial production is poised to begin as soon as final statutory geometrical clearances and other regulatory approvals are received.
- Sales start: Management expects Dhule SSP sales to begin within 10 days of the call date; the plant is capable of producing all types of NPK, DAP and SSP with various compositions, with product mix shifting based on raw material prices and demand.
- H2 utilization: Capacity utilization for the new facility in the second half is estimated at 40% to 50%; management notes a bigger plant has teething problems once production starts, and declined to provide quarter-wise ramp-up assumptions.
- FY28 utilization: Expected to reach 70% comfortably in FY28, despite teething problems from the secondhand plant procured from Birla Copper.
- Next expansion phase: An additional 3,30,000 MTPA DAP/NPK, 66,000 MTPA phosphoric acid, and 1,98,000 MTPA sulphuric acid capacity announced for Dhule, targeting total capacity of ~0.16 crore metric tons per annum by FY28; exact capex still being finalized.
- Incremental revenue opportunity: The expansion creates a potential ~₹3,500 crores of incremental revenue, to be achieved in a phased manner, not an immediate target; capacity creates potential and management expects to achieve the numbers with experience.
Sourabh Gupta: "And as the history speaks, the Madhya Bharat or for that region Ostwal Group, they have always excelled the estimate even. So rest assured, we will have better performance."
Margin Structure & Sustainability
- Q2 margin spike: The 18% EBITDA margin in Q2 was an exception caused by the new subsidy policy release, which brought higher revenue from government on account of stocks present in the market.
- Sustainable range: 12% to 14% EBITDA is the normal sustainable level, achieved consistently over the last nine years; management stated that higher margins on a regular basis are not possible because fertilizer must be provided at a reasonable price.
- H1 margin benefit: H1 FY27 EBITDA margin was higher due to declaration of new subsidy figures; the Q2 expansion was also driven by disciplined procurement, diversified sourcing, and integrated manufacturing, though management declined to break down the contribution by product mix, raw material cost, or operating leverage.
- New capacity margin impact: The Dhule facility will add absolute EBITDA but is not expected to increase the margin percentage; the 12–14% range remains the going-in assumption.
- Ammonia price risk: An analyst asked whether elevated ammonia raw material prices in Q2 would compress Q3 margins; management declined to comment, stating only that they are monitoring prices and are confident of achieving production targets and good results.
Pankaj Ostwal: "18%, this is an exception for this H1, because the new subsidy policy has released, and there is higher revenue coming from government on account of the stocks which are present in the market."
Demand & Volume Recovery
- H1 NPK/DAP softness: A marginal decrease in H1 NPK and DAP sales versus H1 FY26, attributed to global issues with raw material, finished goods, and transit; management confident of making up the shortfall in coming quarters by balancing manufacturing with imports.
- Inventory overhang: Inventory levels are high because of less NPK and DAP sales than expected, adding to the working capital pressure.
- Demand conviction: Management expressed zero concern about ultimate offtake, stating fertilizer is a product already in demand across the country and selling has never been an issue; timing may shift by 15 days but the product will be sold.
- Rabi 2026-2027 outlook: Cautiously optimistic, citing strong policy tailwinds: NBS hike, sulphur price support, freight subsidies for SSP, higher MSP for Rabi crops; a structural push toward balanced nutrient application creates strong runway for complex NPK fertilizers.
Pankaj Ostwal: "Fertilizer has been a product which is already in demand across the country. So selling has never been an issue and it will never — it will not be an issue for sales. It can be time or timed effort. It can be 15 days here or there. It cannot be that the product will not be sold."
Balance Sheet & Working Capital
- Trade receivables spike: Trade receivables reached ₹632 crores at Q2 close, attributed to business growth, inclusion of government subsidies, and lopsided sales in Q2 due to delayed monsoon; Q2 sales are expected to be realized in Q3. Management characterized this as a one-time aberration and stated all debtors are of good quality.
- Normalization timeline: The September aberration is expected to be set right in the coming six months.
- Capital raise: The company raised ~₹300 crores via a preferential issue of equity shares, strengthening the balance sheet ahead of the Dhule ramp.
Backward Integration & Procurement Strategy
- Phosphoric acid: Always produced in-house because buying directly from the market has never been beneficial.
- Sulphuric acid: The company opportunistically buys from producers where it is a byproduct sold under compulsion at reasonable prices, adjusting the mix of in-house production versus procurement for best benefit.
- Raw material environment: Geopolitical tensions in West Asia and Strait of Hormuz transit uncertainties kept freight, insurance, and raw material costs elevated, particularly for phosphoric acid and sulphur; ammonia softened and rock phosphate remained stable. MBAPL navigated the volatility through diversified procurement and its integrated manufacturing setup.
- Backward integration utilization: Facilities will be utilized at optimum and conservative levels despite raw material price volatility, providing value addition.
Sourabh Gupta: "In case of sulphuric acid, there are opportunities because many producers where this sulphuric acid is a byproduct, under compulsion they sell at very reasonable prices. So we take a call at appropriate time how a mix of raw material procurement, backward integration utilization should be used."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Dhule commercial sales start | SSP sales to begin from Dhule facility | Within 10 days of call date |
| Dhule H2 capacity utilization | 40% to 50% utilization of new facility | H2 FY27 |
| Dhule FY28 capacity utilization | 70% utilization | FY28 |
| Sustainable EBITDA margin | 12% to 14% range | Ongoing |
| FY28 revenue | ~₹4,000 crores full-year production | FY28 |
| Working capital normalization | Receivables aberration to be corrected | Coming six months |
| Total capacity target | ~0.16 crore metric tons per annum | By FY28 |
| NPK/DAP H1 volume shortfall recovery | Marginal decrease to be made up via manufacturing and imports | Coming quarters |
Key Metrics
| Metric | Q2 FY27 |
|---|---|
| Revenue from operations | ₹715 cr, +59% YoY |
| EBITDA | ₹128 cr, +107% YoY |
| EBITDA margin | 18%, up from ~12% in FY26; elevated by new subsidy declaration |
| Profit after tax | ₹78 cr, +155% YoY |
| EPS | ₹1.76, vs ₹0.70 in Q2 FY26 |
| H1 FY27 revenue from operations | ₹1,135 cr, +32% YoY |
| H1 FY27 EBITDA | ₹197 cr, +66% YoY |
| H1 FY27 EBITDA margin | 17% |
| H1 FY27 PAT | ₹111 cr, +89% YoY |
| H1 FY27 EPS | ₹2.52, vs ₹1.34 in H1 FY26 |
| H1 FY27 production volumes | 2 lakh metric tons |
| H1 FY27 sales volumes | 2.32 lakh metric tons |
| Trade receivables | ₹632 cr, includes government subsidies; elevated due to Q2 sales skew |
| Sustainable EBITDA margin guidance | 12% to 14%, management's long-term expectation |
| Dhule H2 capacity utilization estimate | 40% to 50%, for the newly commissioned facility |
| Dhule FY28 capacity utilization target | 70% |
| FY28 revenue guidance | ~₹4,000 cr, full-year target |
| Capital raised via preferential issue | ~₹300 cr, of which ₹192 cr for working capital, ₹333 cr for Dhule capex, ₹75 cr for general corporate purposes |
| NBS outlay hike for Rabi 2026-2027 | 64% increase to ₹62,370 cr, up from ₹37,952 cr last Rabi season |